Cycle and Stroke With Biofeedback for Power Symmetry
Launched by UNIVERSITY OF UTAH · Feb 27, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special exercise program using a recumbent cycle with biofeedback can help improve walking abilities in people who have had a stroke. The goal is to see if this program can make walking more balanced and functional for participants, who often struggle with uneven walking patterns after a stroke. By using the cycle, participants can receive feedback on their leg strength and movement, which can help therapists better understand and address their walking difficulties.
To be eligible for this trial, participants need to be between 18 and 70 years old and have experienced a specific type of stroke that affects their ability to move one side of their body. They should be able to walk with some assistance but may still need help getting around. During the trial, participants can expect to engage in guided exercises that aim to enhance their walking skills while receiving support and feedback from the therapists. It’s important to note that individuals with certain health issues or severe mobility limitations may not qualify for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. they have a confirmed MCA or ACA ischemic or intracerebral hemorrhagic stroke, confirmed by CT/MRI or clinical documentation
- • -AND demonstrating lower extremity hemiparesis \[\< 100 on lower limb Motricity Index24\]
- • 2. 18 to 70 years of age
- • 3. a Functional Ambulation Category of 2 (Dependent Level II) through 5 (Independent Level surfaces only)
- • 4. medical clearance to participate
- Exclusion Criteria:
- • 1. contractures that limit lower limb range of motion
- • 2. cardiovascular, respiratory or metabolic instability, including unstable angina or hypertension above 200/110 at rest
- • 3. uncontrolled diabetes
- • 4. severe respiratory disorders that limit exercise
- • 5. inability to ambulate \> 150 feet prior to stroke
- • 6. prior history of peripheral or central nervous system injury
- • 7. moderate to severe hemispatial neglect according to the Kessler Foundation Neglect Assessment
- • 8. major cognitive impairment preventing the capability to understand training instructions; identified by inability to follow 3-step command
- • 9. severe aphasia preventing communication with the therapist.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Heather A Hayes, PhD
Principal Investigator
University of Utah
James C Martin, PhD
Principal Investigator
University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported